Jump Financial, LLC Ngm Biopharmaceuticals Inc Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 21, 2024	BUY	$3.72 - $5.4 $135,408 - $196,560	36,400 New	36,400 $148,000
Q1 2023 May 03, 2023	BUY	$3.72 - $5.4 $135,408 - $196,560	36,400 New	36,400 $148,000
Q3 2022 Nov 07, 2022	BUY	$12.59 - $17.67 $35,252 - $49,476	2,800 Added 9.79%	31,400 $411,000
Q2 2022 Aug 09, 2022	BUY	$10.58 - $17.5 $49,726 - $82,250	4,700 Added 19.67%	28,600 $367,000
Q1 2022 May 12, 2022	SELL	$13.81 - $18.6 $62,145 - $83,700	-4,500 Reduced 15.85%	23,900 $364,000
Q4 2021 Feb 10, 2022	BUY	$17.26 - $22.02 $246,403 - $314,357	14,276 Added 101.08%	28,400 $503,000
Q3 2021 Nov 12, 2021	BUY	$20.15 - $26.19 $284,598 - $369,907	14,124 New	14,124 $297,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.